v3.26.1
Stockholders’ Equity
 3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Stockholders’ Equity Stockholders’ Equity
Preferred stock
Our board of directors has the authority, without further action by our stockholders, to issue up to 25,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, and privileges thereof, including voting rights. As of March 31, 2026 and December 31, 2025, no shares of this preferred stock were issued and outstanding.
Common stock
We had 500,000,000 shares of common stock, par value $0.001 per share, authorized, of which 73,854,862 and 72,133,528 shares were legally issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. The shares legally issued and outstanding as of March 31, 2026 and December 31, 2025 included 106,196 shares issued pursuant to acquisition agreements, which were subject to a restriction agreement and were unvested, and as such, for accounting purposes they were not considered to be outstanding common stock shares. Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the board of directors, subject to prior rights of holders of all classes of stock outstanding having priority rights as to dividends. No dividends have been declared or paid on our common stock through March 31, 2026.

Share repurchase plan
During the third quarter of 2022, our board of directors authorized a share repurchase program to repurchase up to $40.0 million of our outstanding shares of common stock (Share Repurchase Plan). During the three months ended March 31, 2026, we did not repurchase shares of our common stock. During the three months ended March 31, 2025, we repurchased and retired 1,103,601 shares of our common stock for $5.0 million at an average purchase price of $4.51 per share. The total remaining authorization for future shares of common stock repurchases under our Share Repurchase Plan is $24.8 million as of March 31, 2026.
Accumulated Other Comprehensive Income
Components of accumulated other comprehensive income were as follows (in thousands):
Foreign Currency Translation Adjustment
Unrealized Gain (Loss) on Available for Sale Investments
Total
Balance as of December 31, 2025
$1,539 $47 $1,586 
Change in foreign currency translation adjustment
(511)— (511)
Change in net unrealized gains (losses) on available for sale investments
— (66)(66)
Balance as of March 31, 2026
$1,028 $(19)$1,009 
There were no material reclassifications out of accumulated other comprehensive income during the three months ended March 31, 2026. Additionally, as we record a full valuation allowance against our U.S. and U.K. net deferred tax assets and substantially all of our accumulated other comprehensive income originated in the U.S. and U.K., other comprehensive income (loss) does not include significant income tax expense.